Highlights Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-13 pm EDT			5-day change	1st Jan Change
4.720 ^USD	-0.84%		-6.72%	-25.79%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Highlights

Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Mar. 02	Quanterix Provides Earnings Guidance for the Year 2026	CI
Mar. 02	Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide	CI
Feb. 03	Quanterix Files 510(k) With FDA for Alzheimer's Blood Test	MT
Feb. 03	Quanterix announces FDA 510(k) submission for a multi-analyte algorithmic blood test for Alzheimer’s disease detection	RE
Feb. 03	Quanterix Corporation Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection	CI
Jan. 21	Quanterix Corporation Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling	CI
Dec. 22	Quanterix announces landmark Nature study redefining Alzheimer's disease Neuropathology prevalence	RE
Nov. 17	Quanterix Corporation Announces the Publication of A Landmark Study in the High-Imp Impacted Journal Brain	CI
Nov. 10	Quanterix Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 10	Quanterix Corporation Updates Earnings Guidance for the Year 2025	CI
Nov. 10	Quanterix Q3 revenue rises on Alzheimer's diagnostics business	RE
25-08-21	Quanterix Accelerator Laboratory Gets New York State Permit	MT
25-08-07	Quanterix Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-08-07	Quanterix Q2 revenue falls 29%, net loss widens	RE
25-08-07	Quanterix Corporation Provides Earnings Guidance for 2025	CI
25-08-04	Quanterix Corporation Enters into Cooperation Agreement with Kent Lake Partners LP	CI
25-07-28	Quanterix Corporation Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC	CI
25-07-08	Quanterix and Akoya Biosciences Announces Executive and Board Changes	CI
25-07-08	Quanterix Completes Akoya Biosciences Acquisition	MT
25-07-08	Akoya Biosciences Completes Merger with Quanterix Corporation	CI
25-07-08	Quanterix Completes Acquisition of Akoya Biosciences	CI
25-07-07	Quanterix Corporation completed the acquisition of Akoya Biosciences, Inc. from PSC Capital Partners LLC, aMoon Growth Fund II, L.P., a fund managed by aMoon Fund, Blue Water Life Science Advisors, LP and others.	CI
25-07-07	Akoya Biosciences Stockholders Approve Merger Proposal and Adjournment at Special Meeting	CI
25-06-23	Quanterix Corporation Expands Reach with IVD and Large Reference Labs	CI